Last reviewed · How we verify

Intradialytic parenteral nutrition — Competitive Intelligence Brief

Intradialytic parenteral nutrition (Intradialytic parenteral nutrition) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nutritional supplement / parenteral nutrition formulation. Area: Nephrology / Renal disease.

marketed Nutritional supplement / parenteral nutrition formulation Nephrology / Renal disease Small molecule Live · refreshed every 30 min

Target snapshot

Intradialytic parenteral nutrition (Intradialytic parenteral nutrition) — EZUS-LYON 1. Intradialytic parenteral nutrition (IDPN) delivers intravenous amino acids, dextrose, and lipids directly into the bloodstream during hemodialysis sessions to supplement nutritional intake in malnourished dialysis patients.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Intradialytic parenteral nutrition TARGET Intradialytic parenteral nutrition EZUS-LYON 1 marketed Nutritional supplement / parenteral nutrition formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nutritional supplement / parenteral nutrition formulation class)

  1. EZUS-LYON 1 · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intradialytic parenteral nutrition — Competitive Intelligence Brief. https://druglandscape.com/ci/intradialytic-parenteral-nutrition. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: